University College London: Advanced Lung Cancer Patients Lived 56% Longer Progression-free With Added Radiotherapy
October 27, 2026
October 27, 2026
LONDON, England, Oct. 27 -- The University College London posted the following news:
* * *
Advanced lung cancer patients lived 56% longer progression-free with added radiotherapy
Primary results from a UCL sponsored trial found the addition of radiotherapy to treatment plans improved progression-free survival from 8.9 to 13.9 months
25 October 2026
Patients with an advanced form of lung cancer lived 56% longer without their disease . . .
* * *
Advanced lung cancer patients lived 56% longer progression-free with added radiotherapy
Primary results from a UCL sponsored trial found the addition of radiotherapy to treatment plans improved progression-free survival from 8.9 to 13.9 months
25 October 2026
Patients with an advanced form of lung cancer lived 56% longer without their disease . . .
